RAPIRUN H. PYLORI ANTIBODY DETECTION KIT— 510(k) K052716

Name: FDA 510(k) clearance K052716
Creator: U.S. Food and Drug Administration
Published: 2006-11-16

Substantially Equivalent

Otsuka Pharmaceutical Co., Ltd.

FDA 510(k) clearance K052716 for RAPIRUN H. PYLORI ANTIBODY DETECTION KIT, Substantially Equivalent on 2006-11-16. Applicant: Otsuka Pharmaceutical Co., Ltd.. Device class: 1.

Clearance details

Applicant: Otsuka Pharmaceutical Co., Ltd.
Product code: Code LYR
Device class: Class 1
Regulation: 21 CFR 866.3110
Advisory panel: Microbiology
Date received: 2005-09-29
Decision date: 2006-11-16
Decision: Substantially Equivalent
Clearance type: Traditional
Location: North Attleboro, MA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code LYR

view all

K232892 — Hp Detect Stool Antigen ELISA2023-12-15
K230901 — Premier HpSA Flex (619096)2023-07-03
K192817 — Curian HpSA, Curian Analyzer2020-03-13
K183573 — Vstrip H. pylori Antigen Rapid Test2019-03-14
K182559 — PREMIER Platinum HpSA PLUS2018-11-05

More clearances from Otsuka Pharmaceutical Co., Ltd.

view all

K092817 — POC-AS10 AUTO SAMPLER2010-03-09
K041148 — POCONE INFRARED SPECTROPHOTOMETER2004-07-15
K013371 — UBIT-IR300 INFRARED SPECTROMETRY SYSTEM2001-12-21
K001032 — RLP-CHOLESTEROL IMMUNOSEPARATION ASSAY2000-07-24
K991083 — RLP CHOLESTEROL IMMUNOSEPARATION ASSAY1999-08-20

Adverse events under product code LYR

product code LYR

Other: 1
Total: 1

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.